Egan Colin G, Lockhart John C, Ferrell William R
Biological Sciences, University of Paisley, Paisley PA1 2BE, UK.
J Physiol. 2004 Jun 1;557(Pt 2):635-43. doi: 10.1113/jphysiol.2004.062984. Epub 2004 Apr 2.
The impact of chronic joint inflammation on articular vascular function in rats was investigated to address whether joint swelling and the associated vascular dysfunction are dependent upon a common prostanoid mechanism. Urinary nitrate/nitrite (NO(x)) and PGE(2) excretion, knee joint diameter and body weight were measured following induction of adjuvant-induced arthritis (AIA). Ten days postinduction of AIA, joint vascular reactivity was assessed by measuring the perfusion response using a laser Doppler imager (LDI) to topical application of acetylcholine (ACh) and sodium nitroprusside (SNP). Four groups were compared: a non-inflamed control group and three AIA groups treated i.p. with vehicle, indomethacin or SC-236 (at equimolar doses). The selective cyclooxygenase-2 (COX-2) inhibitor (SC-236) was used to differentiate between COX-1 and -2-derived prostaglandins. Urinary NO(x) and PGE(2) levels increased substantially during the early phase of AIA but decreased thereafter. Toxicity to indomethacin but not SC-236 was observed, as indicated by a marked decrease in body weight. Joint swelling was similarly attenuated by indomethacin and SC-236 (P= 0.0001 cf. vehicle-treated AIA; n= 5-6 per group), indicating that this is due to COX-2 and not COX-1 inhibition. The AIA-induced changes in urinary NO(x) and PGE(2) were corrected by both COX inhibitors. While vascular reactivity to ACh and SNP was significantly attenuated by AIA (P < 0.002; n= 5-10 per group), the perfusion responses to these vasodilating agents were similar in all three AIA groups, demonstrating that the vascular dysfunction was not corrected by inhibition of either COX-1 or COX-2 enzymes. Furthermore, the attenuation of both ACh and SNP-induced responses in AIA suggest that vascular dysfunction was not exclusively endothelial in nature. In conclusion, the joint swelling and vascular dysfunction associated with AIA appear to be mediated, at least in part, by independent mechanisms. While COX-1/COX-2 inhibition reduced joint swelling, vascular dysfunction in AIA is independent of constitutive or inducible prostanoid mechanisms, and appears not to be solely endothelial-derived, but to involve other components such as the vascular smooth muscle.
为了探究慢性关节炎症对大鼠关节血管功能的影响,以确定关节肿胀及相关血管功能障碍是否依赖于共同的前列腺素机制。在诱导佐剂性关节炎(AIA)后,测量大鼠尿中硝酸盐/亚硝酸盐(NO(x))和前列腺素E2(PGE(2))的排泄量、膝关节直径和体重。诱导AIA后10天,通过使用激光多普勒成像仪(LDI)测量局部应用乙酰胆碱(ACh)和硝普钠(SNP)后的灌注反应,评估关节血管反应性。比较四组:非炎症对照组和三组经腹腔注射赋形剂、吲哚美辛或SC-236(等摩尔剂量)处理的AIA组。使用选择性环氧化酶-2(COX-2)抑制剂(SC-236)来区分COX-1和COX-2衍生的前列腺素。在AIA早期,尿中NO(x)和PGE(2)水平大幅升高,但随后下降。观察到吲哚美辛有毒性而SC-236没有,表现为体重显著下降。吲哚美辛和SC-236同样减轻了关节肿胀(P = 0.0001,与赋形剂处理的AIA组相比;每组n = 5 - 6),表明这是由于COX-2而非COX-1受到抑制。两种COX抑制剂均纠正了AIA诱导的尿中NO(x)和PGE(2)的变化。虽然AIA显著减弱了对ACh和SNP的血管反应性(P < 0.002;每组n = 5 - 10),但在所有三个AIA组中,对这些血管扩张剂的灌注反应相似,表明抑制COX-1或COX-2酶并不能纠正血管功能障碍。此外,AIA中ACh和SNP诱导反应的减弱表明,血管功能障碍并非完全由内皮细胞引起。总之,与AIA相关的关节肿胀和血管功能障碍似乎至少部分由独立机制介导。虽然COX-1/COX-2抑制减轻了关节肿胀,但AIA中的血管功能障碍独立于组成型或诱导型前列腺素机制,似乎并非仅源于内皮细胞,而是涉及其他成分,如血管平滑肌。